Aimei Health Technology (NASDAQ:AFJK) Issues Earnings Results

Aimei Health Technology (NASDAQ:AFJK) posted its quarterly earnings results on Tuesday. The company reported $0.01 earnings per share for the quarter, FiscalAI reports.

Aimei Health Technology Price Performance

Shares of NASDAQ AFJK opened at $33.91 on Thursday. The stock’s fifty day moving average price is $41.77 and its two-hundred day moving average price is $41.01. Aimei Health Technology has a one year low of $6.75 and a one year high of $130.37. The firm has a market cap of $107.35 million, a price-to-earnings ratio of 211.93 and a beta of 0.22.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the company. Clear Street Group Inc. grew its holdings in Aimei Health Technology by 36.5% in the 4th quarter. Clear Street Group Inc. now owns 83,337 shares of the company’s stock valued at $5,334,000 after buying an additional 22,294 shares in the last quarter. Jane Street Group LLC acquired a new position in Aimei Health Technology in the 4th quarter valued at $302,000. Geode Capital Management LLC acquired a new position in Aimei Health Technology in the 4th quarter valued at $413,000. Dakota Wealth Management acquired a new position in Aimei Health Technology in the 4th quarter valued at $406,000. Finally, Quarry LP grew its holdings in Aimei Health Technology by 6.4% in the 3rd quarter. Quarry LP now owns 167,081 shares of the company’s stock valued at $1,891,000 after buying an additional 10,000 shares in the last quarter. 45.58% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Separately, Weiss Ratings restated a “sell (d+)” rating on shares of Aimei Health Technology in a research note on Friday, March 27th. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat, the company currently has an average rating of “Sell”.

About Aimei Health Technology

Aimei Health Technology Co, Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. It intends to acquires businesses in the biopharmaceutical, medical technology/device industries or diagnostic, and other services sectors. Aimei Health Technology Co, Ltd was incorporated in 2023 and is based in New York, New York.